PeptidePlaza
The Free Peptide Reference

Insulin Susp Isophane Semisynthetic Purified Human

From PeptidePlaza, the free peptide reference · Entry #1073 · Metabolic · Sources fetched 2026-09-11 · Editorial standards

Insulin Susp Isophane Semisynthetic Purified Human is a metabolic research peptide. Insulin Susp Isophane Semisynthetic Purified Human is an insulin receptor agonist that is FDA approved.

Insulin Susp Isophane Semisynthetic Purified Human is a semisynthetic purified human insulin. It functions as an insulin receptor agonist, activating the insulin receptor. This compound has been investigated for its potential in treating various conditions, including hypertension, atherosclerosis, hypercholesterolemia, coronary disease, and type 2 diabetes mellitus, all of which have reached Phase 3 clinical trials. It has also been studied for hyperglycemia in Phase 2 trials. The compound received FDA approval in 1985.

1 Mechanism of action

Insulin receptor agonist (agonist)

Primary targets: Insulin receptor

2 Reported effects

Effects below are those reported in the published literature cited on this page. They are not claims of clinical benefit and not medical advice.

2.1 Indicated / studied for

  • Hypertension
  • Atherosclerosis
  • Hypercholesterolemia
  • Coronary Disease
  • Diabetes Mellitus, Type 2
  • Hyperglycemia

3 Chemical and physical properties

Purity (typical)Not independently verified
Storage−20 °C, lyophilised powder, desiccated
SolubilitySterile water / bacteriostatic water
Receptors / targetsInsulin receptor

4 Safety and risk profile

4.1 Regulatory status

Insulin Susp Isophane Semisynthetic Purified Human is currently classified as FDA approved. Approval applies to specific clinical indications and dosing; research-grade material is not the approved product.

Safety data disclaimer. Safety assessments are based on published literature and are for educational reference only. Clinical evidence varies significantly between peptides. Always consult primary research and current regulatory guidance.

5 Frequently asked questions

What is Insulin Susp Isophane Semisynthetic Purified Human?
Insulin Susp Isophane Semisynthetic Purified Human is a semisynthetic purified human insulin. It is classified as an insulin receptor agonist, meaning it activates the insulin receptor to exert its effects within the body.
How does Insulin Susp Isophane Semisynthetic Purified Human work?
Insulin Susp Isophane Semisynthetic Purified Human works by acting as an agonist for the insulin receptor. This mechanism involves binding to and activating the insulin receptor, which is crucial for regulating glucose metabolism and cellular growth.
What is Insulin Susp Isophane Semisynthetic Purified Human used for?
Insulin Susp Isophane Semisynthetic Purified Human has been studied for several conditions, including hypertension, atherosclerosis, hypercholesterolemia, coronary disease, and type 2 diabetes mellitus. It has also been investigated for hyperglycemia.
Is Insulin Susp Isophane Semisynthetic Purified Human FDA approved?
Yes, Insulin Susp Isophane Semisynthetic Purified Human is FDA approved. It received its first approval in the year 1985, indicating its established use in clinical practice.

6 References

  1. Insulin Susp Isophane Semisynthetic Purified Human — molecule record ChEMBL. View source

Related compounds

Entries that share a target, a mechanism, or a research area with Insulin Susp Isophane Semisynthetic Purified Human.

Insulin Glargineapproved

Also targets Insulin receptor

Insulin Glargine is a long-acting human insulin analog and an insulin receptor agonist, FDA-approved to improve glycemic control in patients with type 1 and type 2 diabetes mellitus.

Insulin Aspartapproved

Also targets Insulin receptor

Insulin Aspart is a rapid-acting human insulin analog that functions as an insulin receptor agonist, primarily used to improve glycemic control in patients with diabetes mellitus.

Insulin Lisproapproved

Also targets Insulin receptor

Insulin Lispro, also known as Lyumjev, is a rapid-acting human insulin analog that acts as an insulin receptor agonist.

Insulin Degludecapproved

Also targets Insulin receptor

Insulin Degludec is a long-acting human insulin analog and an insulin receptor agonist, FDA-approved for improving glycemic control in adults with type 2 diabetes mellitus.

Insulin Detemirapproved

Also targets Insulin receptor

Insulin Detemir, also known as Levemir, is a long-acting human insulin analog and an insulin receptor agonist used to improve glycemic control in patients with diabetes mellitus.

Insulin Zincapproved

Also targets Insulin receptor

Insulin Zinc is an insulin receptor agonist that is FDA-approved for medical use.

7 See also

For research reference only. Not medical advice. Peptides may be regulated or restricted in your jurisdiction. Entry validated by the PeptidePlaza Biomedical Research Desk; see editorial standards.